Role of endothelial cells in pulmonary fibrosis via SREBP2 activation

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options. Despite endothelial cells (ECs) comprising 30% of the lung cellular composition, the role of EC dysfunction in pulmonary fibrosis (PF) remains unclear. We hypothesize that sterol regulatory element-bind...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JCI insight 2021-11, Vol.6 (22), Article 125635
Hauptverfasser: Martin, Marcy, Zhang, Jiao, Miao, Yifei, He, Ming, Kang, Jian, Huang, Hsi-Yuan, Chou, Chih-Hung, Huang, Tse-Shun, Hong, Hsiao-Chin, Su, Shu-Han, Wong, Simon S., Harper, Rebecca L., Wang, Lingli, Bhattacharjee, Rakesh, Huang, Hsien-Da, Chen, Zhen Bouman, Malhotra, Atul, Rabinovitch, Marlene, Hagood, James S., Shyy, John Y-J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 22
container_start_page
container_title JCI insight
container_volume 6
creator Martin, Marcy
Zhang, Jiao
Miao, Yifei
He, Ming
Kang, Jian
Huang, Hsi-Yuan
Chou, Chih-Hung
Huang, Tse-Shun
Hong, Hsiao-Chin
Su, Shu-Han
Wong, Simon S.
Harper, Rebecca L.
Wang, Lingli
Bhattacharjee, Rakesh
Huang, Hsien-Da
Chen, Zhen Bouman
Malhotra, Atul
Rabinovitch, Marlene
Hagood, James S.
Shyy, John Y-J
description Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options. Despite endothelial cells (ECs) comprising 30% of the lung cellular composition, the role of EC dysfunction in pulmonary fibrosis (PF) remains unclear. We hypothesize that sterol regulatory element-binding protein 2 (SREBP2) plays a critical role in the pathogenesis of PF via EC phenotypic modifications. Transcriptome data demonstrate that SREBP2 overexpression in ECs led to the induction of the TGF, Wnt, and cytoskeleton remodeling gene ontology pathways and the increased expression of mesenchymal genes, such as snail family transcriptional repressor 1 (snai1), alpha-smooth muscle actin, vimentin, and neural cadherin. Furthermore, SREBP2 directly bound to the promoter regions and transactivated these mesenchymal genes. This transcriptomic change was associated with an epigenetic and phenotypic switch in ECs, leading to increased proliferation, stress fiber formation, and ECM deposition. Mice with endothelial-specific transgenic overexpression of SREBP2 (EC-SREBP2[N]-Tg mice) that were administered bleomycin to induce PF demonstrated exacerbated vascular remodeling and increased mesenchymal transition in the lung. SREBP2 was also found to be markedly increased in lung specimens from patients with IPF. These results suggest that SREBP2, induced by lung injury, can exacerbate PF in rodent models and in human patients with IPF.
doi_str_mv 10.1172/jci.insight.125635
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8663776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a987127f94c64dac82b05abf54e1a92c</doaj_id><sourcerecordid>2600822076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-2e48d9fdb9619e4e996e0c4da820f0663a02becfd156ef395021075338cfbfb3</originalsourceid><addsrcrecordid>eNqNkU1vEzEQhlcIRKvSP8AB7REJJfhj_XVBgijQSpVApXfL6x0njjZ2WHtT8e9xsmnU3jjZsp95ZzRPVb3HaI6xIJ831s99SH61znNMGKfsVXVJqFAzKpB8_ex-UV2ntEEIYdEQxOTb6oI2EnHOyGW1vI891NHVELqY19B709cW-j7VPtS7sd_GYIa_tfPtEJNP9d6b-vf98tsvUhub_d5kH8O76o0zfYLr03lVPXxfPixuZnc_f9wuvt7NbMNlnhFoZKdc1yqOFTSgFAdkm85IglwZiBpEWrCuw4yDo4ohgpFglErrWtfSq-p2iu2i2ejd4LdlNB2N18eHOKy0GbK3PWijpMBEONVYXhpYSVrETOtYA9goYkvWlylrN7Zb6CyEPJj-RejLn-DXehX3WpY5heAl4OMpYIh_RkhZb306bM4EiGPShCMkCUFHlEyoLTtMA7hzG4z0waYuNvXJpp5slqIPzwc8lzy5K8CnCXiENrpkPQQLZ6z4FgSzRkl0UF9o-f_0wuej10UcQ6b_AFj-v0M</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2600822076</pqid></control><display><type>article</type><title>Role of endothelial cells in pulmonary fibrosis via SREBP2 activation</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>PubMed Central</source><creator>Martin, Marcy ; Zhang, Jiao ; Miao, Yifei ; He, Ming ; Kang, Jian ; Huang, Hsi-Yuan ; Chou, Chih-Hung ; Huang, Tse-Shun ; Hong, Hsiao-Chin ; Su, Shu-Han ; Wong, Simon S. ; Harper, Rebecca L. ; Wang, Lingli ; Bhattacharjee, Rakesh ; Huang, Hsien-Da ; Chen, Zhen Bouman ; Malhotra, Atul ; Rabinovitch, Marlene ; Hagood, James S. ; Shyy, John Y-J</creator><creatorcontrib>Martin, Marcy ; Zhang, Jiao ; Miao, Yifei ; He, Ming ; Kang, Jian ; Huang, Hsi-Yuan ; Chou, Chih-Hung ; Huang, Tse-Shun ; Hong, Hsiao-Chin ; Su, Shu-Han ; Wong, Simon S. ; Harper, Rebecca L. ; Wang, Lingli ; Bhattacharjee, Rakesh ; Huang, Hsien-Da ; Chen, Zhen Bouman ; Malhotra, Atul ; Rabinovitch, Marlene ; Hagood, James S. ; Shyy, John Y-J</creatorcontrib><description>Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options. Despite endothelial cells (ECs) comprising 30% of the lung cellular composition, the role of EC dysfunction in pulmonary fibrosis (PF) remains unclear. We hypothesize that sterol regulatory element-binding protein 2 (SREBP2) plays a critical role in the pathogenesis of PF via EC phenotypic modifications. Transcriptome data demonstrate that SREBP2 overexpression in ECs led to the induction of the TGF, Wnt, and cytoskeleton remodeling gene ontology pathways and the increased expression of mesenchymal genes, such as snail family transcriptional repressor 1 (snai1), alpha-smooth muscle actin, vimentin, and neural cadherin. Furthermore, SREBP2 directly bound to the promoter regions and transactivated these mesenchymal genes. This transcriptomic change was associated with an epigenetic and phenotypic switch in ECs, leading to increased proliferation, stress fiber formation, and ECM deposition. Mice with endothelial-specific transgenic overexpression of SREBP2 (EC-SREBP2[N]-Tg mice) that were administered bleomycin to induce PF demonstrated exacerbated vascular remodeling and increased mesenchymal transition in the lung. SREBP2 was also found to be markedly increased in lung specimens from patients with IPF. These results suggest that SREBP2, induced by lung injury, can exacerbate PF in rodent models and in human patients with IPF.</description><identifier>ISSN: 2379-3708</identifier><identifier>EISSN: 2379-3708</identifier><identifier>DOI: 10.1172/jci.insight.125635</identifier><identifier>PMID: 34806652</identifier><language>eng</language><publisher>ANN ARBOR: Amer Soc Clinical Investigation Inc</publisher><subject>Animals ; Endothelial Cells - metabolism ; Humans ; Life Sciences &amp; Biomedicine ; Medicine, Research &amp; Experimental ; Mice ; Pulmonary Fibrosis - genetics ; Pulmonology ; Research &amp; Experimental Medicine ; Science &amp; Technology ; Sterol Regulatory Element Binding Protein 2 - metabolism ; Vascular biology</subject><ispartof>JCI insight, 2021-11, Vol.6 (22), Article 125635</ispartof><rights>2021 Martin et al. 2021 Martin et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>27</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000721549800001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c468t-2e48d9fdb9619e4e996e0c4da820f0663a02becfd156ef395021075338cfbfb3</citedby><cites>FETCH-LOGICAL-c468t-2e48d9fdb9619e4e996e0c4da820f0663a02becfd156ef395021075338cfbfb3</cites><orcidid>0000-0001-5714-1718 ; 0000-0003-0035-0185 ; 0000-0001-7886-7104 ; 0000-0003-3938-0330 ; 0000-0002-3291-1090 ; 0000-0002-5625-753X ; 0000-0003-4882-5629 ; 0000-0001-5871-9067</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663776/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663776/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,39263,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34806652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martin, Marcy</creatorcontrib><creatorcontrib>Zhang, Jiao</creatorcontrib><creatorcontrib>Miao, Yifei</creatorcontrib><creatorcontrib>He, Ming</creatorcontrib><creatorcontrib>Kang, Jian</creatorcontrib><creatorcontrib>Huang, Hsi-Yuan</creatorcontrib><creatorcontrib>Chou, Chih-Hung</creatorcontrib><creatorcontrib>Huang, Tse-Shun</creatorcontrib><creatorcontrib>Hong, Hsiao-Chin</creatorcontrib><creatorcontrib>Su, Shu-Han</creatorcontrib><creatorcontrib>Wong, Simon S.</creatorcontrib><creatorcontrib>Harper, Rebecca L.</creatorcontrib><creatorcontrib>Wang, Lingli</creatorcontrib><creatorcontrib>Bhattacharjee, Rakesh</creatorcontrib><creatorcontrib>Huang, Hsien-Da</creatorcontrib><creatorcontrib>Chen, Zhen Bouman</creatorcontrib><creatorcontrib>Malhotra, Atul</creatorcontrib><creatorcontrib>Rabinovitch, Marlene</creatorcontrib><creatorcontrib>Hagood, James S.</creatorcontrib><creatorcontrib>Shyy, John Y-J</creatorcontrib><title>Role of endothelial cells in pulmonary fibrosis via SREBP2 activation</title><title>JCI insight</title><addtitle>JCI INSIGHT</addtitle><addtitle>JCI Insight</addtitle><description>Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options. Despite endothelial cells (ECs) comprising 30% of the lung cellular composition, the role of EC dysfunction in pulmonary fibrosis (PF) remains unclear. We hypothesize that sterol regulatory element-binding protein 2 (SREBP2) plays a critical role in the pathogenesis of PF via EC phenotypic modifications. Transcriptome data demonstrate that SREBP2 overexpression in ECs led to the induction of the TGF, Wnt, and cytoskeleton remodeling gene ontology pathways and the increased expression of mesenchymal genes, such as snail family transcriptional repressor 1 (snai1), alpha-smooth muscle actin, vimentin, and neural cadherin. Furthermore, SREBP2 directly bound to the promoter regions and transactivated these mesenchymal genes. This transcriptomic change was associated with an epigenetic and phenotypic switch in ECs, leading to increased proliferation, stress fiber formation, and ECM deposition. Mice with endothelial-specific transgenic overexpression of SREBP2 (EC-SREBP2[N]-Tg mice) that were administered bleomycin to induce PF demonstrated exacerbated vascular remodeling and increased mesenchymal transition in the lung. SREBP2 was also found to be markedly increased in lung specimens from patients with IPF. These results suggest that SREBP2, induced by lung injury, can exacerbate PF in rodent models and in human patients with IPF.</description><subject>Animals</subject><subject>Endothelial Cells - metabolism</subject><subject>Humans</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Medicine, Research &amp; Experimental</subject><subject>Mice</subject><subject>Pulmonary Fibrosis - genetics</subject><subject>Pulmonology</subject><subject>Research &amp; Experimental Medicine</subject><subject>Science &amp; Technology</subject><subject>Sterol Regulatory Element Binding Protein 2 - metabolism</subject><subject>Vascular biology</subject><issn>2379-3708</issn><issn>2379-3708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNqNkU1vEzEQhlcIRKvSP8AB7REJJfhj_XVBgijQSpVApXfL6x0njjZ2WHtT8e9xsmnU3jjZsp95ZzRPVb3HaI6xIJ831s99SH61znNMGKfsVXVJqFAzKpB8_ex-UV2ntEEIYdEQxOTb6oI2EnHOyGW1vI891NHVELqY19B709cW-j7VPtS7sd_GYIa_tfPtEJNP9d6b-vf98tsvUhub_d5kH8O76o0zfYLr03lVPXxfPixuZnc_f9wuvt7NbMNlnhFoZKdc1yqOFTSgFAdkm85IglwZiBpEWrCuw4yDo4ohgpFglErrWtfSq-p2iu2i2ejd4LdlNB2N18eHOKy0GbK3PWijpMBEONVYXhpYSVrETOtYA9goYkvWlylrN7Zb6CyEPJj-RejLn-DXehX3WpY5heAl4OMpYIh_RkhZb306bM4EiGPShCMkCUFHlEyoLTtMA7hzG4z0waYuNvXJpp5slqIPzwc8lzy5K8CnCXiENrpkPQQLZ6z4FgSzRkl0UF9o-f_0wuej10UcQ6b_AFj-v0M</recordid><startdate>20211122</startdate><enddate>20211122</enddate><creator>Martin, Marcy</creator><creator>Zhang, Jiao</creator><creator>Miao, Yifei</creator><creator>He, Ming</creator><creator>Kang, Jian</creator><creator>Huang, Hsi-Yuan</creator><creator>Chou, Chih-Hung</creator><creator>Huang, Tse-Shun</creator><creator>Hong, Hsiao-Chin</creator><creator>Su, Shu-Han</creator><creator>Wong, Simon S.</creator><creator>Harper, Rebecca L.</creator><creator>Wang, Lingli</creator><creator>Bhattacharjee, Rakesh</creator><creator>Huang, Hsien-Da</creator><creator>Chen, Zhen Bouman</creator><creator>Malhotra, Atul</creator><creator>Rabinovitch, Marlene</creator><creator>Hagood, James S.</creator><creator>Shyy, John Y-J</creator><general>Amer Soc Clinical Investigation Inc</general><general>American Society for Clinical Investigation</general><general>American Society for Clinical investigation</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5714-1718</orcidid><orcidid>https://orcid.org/0000-0003-0035-0185</orcidid><orcidid>https://orcid.org/0000-0001-7886-7104</orcidid><orcidid>https://orcid.org/0000-0003-3938-0330</orcidid><orcidid>https://orcid.org/0000-0002-3291-1090</orcidid><orcidid>https://orcid.org/0000-0002-5625-753X</orcidid><orcidid>https://orcid.org/0000-0003-4882-5629</orcidid><orcidid>https://orcid.org/0000-0001-5871-9067</orcidid></search><sort><creationdate>20211122</creationdate><title>Role of endothelial cells in pulmonary fibrosis via SREBP2 activation</title><author>Martin, Marcy ; Zhang, Jiao ; Miao, Yifei ; He, Ming ; Kang, Jian ; Huang, Hsi-Yuan ; Chou, Chih-Hung ; Huang, Tse-Shun ; Hong, Hsiao-Chin ; Su, Shu-Han ; Wong, Simon S. ; Harper, Rebecca L. ; Wang, Lingli ; Bhattacharjee, Rakesh ; Huang, Hsien-Da ; Chen, Zhen Bouman ; Malhotra, Atul ; Rabinovitch, Marlene ; Hagood, James S. ; Shyy, John Y-J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-2e48d9fdb9619e4e996e0c4da820f0663a02becfd156ef395021075338cfbfb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Endothelial Cells - metabolism</topic><topic>Humans</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Medicine, Research &amp; Experimental</topic><topic>Mice</topic><topic>Pulmonary Fibrosis - genetics</topic><topic>Pulmonology</topic><topic>Research &amp; Experimental Medicine</topic><topic>Science &amp; Technology</topic><topic>Sterol Regulatory Element Binding Protein 2 - metabolism</topic><topic>Vascular biology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martin, Marcy</creatorcontrib><creatorcontrib>Zhang, Jiao</creatorcontrib><creatorcontrib>Miao, Yifei</creatorcontrib><creatorcontrib>He, Ming</creatorcontrib><creatorcontrib>Kang, Jian</creatorcontrib><creatorcontrib>Huang, Hsi-Yuan</creatorcontrib><creatorcontrib>Chou, Chih-Hung</creatorcontrib><creatorcontrib>Huang, Tse-Shun</creatorcontrib><creatorcontrib>Hong, Hsiao-Chin</creatorcontrib><creatorcontrib>Su, Shu-Han</creatorcontrib><creatorcontrib>Wong, Simon S.</creatorcontrib><creatorcontrib>Harper, Rebecca L.</creatorcontrib><creatorcontrib>Wang, Lingli</creatorcontrib><creatorcontrib>Bhattacharjee, Rakesh</creatorcontrib><creatorcontrib>Huang, Hsien-Da</creatorcontrib><creatorcontrib>Chen, Zhen Bouman</creatorcontrib><creatorcontrib>Malhotra, Atul</creatorcontrib><creatorcontrib>Rabinovitch, Marlene</creatorcontrib><creatorcontrib>Hagood, James S.</creatorcontrib><creatorcontrib>Shyy, John Y-J</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>JCI insight</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martin, Marcy</au><au>Zhang, Jiao</au><au>Miao, Yifei</au><au>He, Ming</au><au>Kang, Jian</au><au>Huang, Hsi-Yuan</au><au>Chou, Chih-Hung</au><au>Huang, Tse-Shun</au><au>Hong, Hsiao-Chin</au><au>Su, Shu-Han</au><au>Wong, Simon S.</au><au>Harper, Rebecca L.</au><au>Wang, Lingli</au><au>Bhattacharjee, Rakesh</au><au>Huang, Hsien-Da</au><au>Chen, Zhen Bouman</au><au>Malhotra, Atul</au><au>Rabinovitch, Marlene</au><au>Hagood, James S.</au><au>Shyy, John Y-J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of endothelial cells in pulmonary fibrosis via SREBP2 activation</atitle><jtitle>JCI insight</jtitle><stitle>JCI INSIGHT</stitle><addtitle>JCI Insight</addtitle><date>2021-11-22</date><risdate>2021</risdate><volume>6</volume><issue>22</issue><artnum>125635</artnum><issn>2379-3708</issn><eissn>2379-3708</eissn><abstract>Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options. Despite endothelial cells (ECs) comprising 30% of the lung cellular composition, the role of EC dysfunction in pulmonary fibrosis (PF) remains unclear. We hypothesize that sterol regulatory element-binding protein 2 (SREBP2) plays a critical role in the pathogenesis of PF via EC phenotypic modifications. Transcriptome data demonstrate that SREBP2 overexpression in ECs led to the induction of the TGF, Wnt, and cytoskeleton remodeling gene ontology pathways and the increased expression of mesenchymal genes, such as snail family transcriptional repressor 1 (snai1), alpha-smooth muscle actin, vimentin, and neural cadherin. Furthermore, SREBP2 directly bound to the promoter regions and transactivated these mesenchymal genes. This transcriptomic change was associated with an epigenetic and phenotypic switch in ECs, leading to increased proliferation, stress fiber formation, and ECM deposition. Mice with endothelial-specific transgenic overexpression of SREBP2 (EC-SREBP2[N]-Tg mice) that were administered bleomycin to induce PF demonstrated exacerbated vascular remodeling and increased mesenchymal transition in the lung. SREBP2 was also found to be markedly increased in lung specimens from patients with IPF. These results suggest that SREBP2, induced by lung injury, can exacerbate PF in rodent models and in human patients with IPF.</abstract><cop>ANN ARBOR</cop><pub>Amer Soc Clinical Investigation Inc</pub><pmid>34806652</pmid><doi>10.1172/jci.insight.125635</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-5714-1718</orcidid><orcidid>https://orcid.org/0000-0003-0035-0185</orcidid><orcidid>https://orcid.org/0000-0001-7886-7104</orcidid><orcidid>https://orcid.org/0000-0003-3938-0330</orcidid><orcidid>https://orcid.org/0000-0002-3291-1090</orcidid><orcidid>https://orcid.org/0000-0002-5625-753X</orcidid><orcidid>https://orcid.org/0000-0003-4882-5629</orcidid><orcidid>https://orcid.org/0000-0001-5871-9067</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2379-3708
ispartof JCI insight, 2021-11, Vol.6 (22), Article 125635
issn 2379-3708
2379-3708
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8663776
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central
subjects Animals
Endothelial Cells - metabolism
Humans
Life Sciences & Biomedicine
Medicine, Research & Experimental
Mice
Pulmonary Fibrosis - genetics
Pulmonology
Research & Experimental Medicine
Science & Technology
Sterol Regulatory Element Binding Protein 2 - metabolism
Vascular biology
title Role of endothelial cells in pulmonary fibrosis via SREBP2 activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T00%3A51%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20endothelial%20cells%20in%20pulmonary%20fibrosis%20via%20SREBP2%20activation&rft.jtitle=JCI%20insight&rft.au=Martin,%20Marcy&rft.date=2021-11-22&rft.volume=6&rft.issue=22&rft.artnum=125635&rft.issn=2379-3708&rft.eissn=2379-3708&rft_id=info:doi/10.1172/jci.insight.125635&rft_dat=%3Cproquest_pubme%3E2600822076%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2600822076&rft_id=info:pmid/34806652&rft_doaj_id=oai_doaj_org_article_a987127f94c64dac82b05abf54e1a92c&rfr_iscdi=true